We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing

News   Mar 10, 2017 | Original Story from ImmunoMet

 
ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing
 
 
 

RELATED ARTICLES

Mouse Study Proposals Promising Parkinson's Molecule

News

A promising molecule has offered hope for a new treatment that could stop or slow Parkinson's. Researchers have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson's, as well as protect the dopamine-producing brain cells from dying.

READ MORE

Novel Drug Targets Advanced Kidney Cancer

News

Scientists have reported promising activity of a novel drug called MK-6482, that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease. The study authors concluded that the drug was well-tolerated with a favorable safety profile.

READ MORE

Saving Cells From Ice Damage

News

Researchers have set the stage for designing polymers that can effectively prevent the growth of ice that damages cells during storage.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE